Back to top

Myriad Genetics Inc: (BATS: MYGN)

(U.S: BATS) As of Jul 30, 2014 03:35 PM ET

 Add to portfolio

 ZacksTrade Now

$36.84 USD

36.84

-0.21 (-0.57%)

Volume: 321,629

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Income Statements

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Sales NA 613 496 402 363
Cost Of Goods NA 80 65 47 44
Gross Profit NA 534 431 355 318
Selling & Adminstrative & Depr. & Amort Expenses 0 306 251 198 183
Income After Depreciation & Amortization 0 228 180 158 135
Non-Operating Income NA 5 4 2 6
Interest Expense NA 0 0 0 0
Pretax Income NA 233 185 160 141
Income Taxes NA 86 72 59 -11
Minority Interest NA 0 0 0 0
Investment Gains/Losses NA 0 0 0 0
Other Income/Charges NA 0 0 0 0
Income From Cont. Operations NA 147 112 101 152
Extras & Discontinued Operations NA 0 0 0 0
Net Income NA 147 112 101 152
Depreciation Footnote 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Income Before Depreciation & Amortization 0 237 189 165 142
Depreciation & Amortization (Cash Flow) NA 9 9 7 7
Income After Depreciation & Amortization 0 228 180 158 135
Earnings Per Share Data 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Average Shares NA 83.33 86.47 91.70 99.15
Diluted EPS Before Non-Recurring Items NA 1.77 1.30 1.10 1.39
Diluted Net EPS NA 1.77 1.30 1.10 1.54

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Sales NA 182.92 204.06 202.47 174.12
Cost Of Goods NA 26.60 26.13 25.48 22.08
Gross Profit NA 156.31 177.92 176.98 152.05
SG&A, R&D, and Dept/Amort Expenses 0.00 101.02 94.93 94.07 86.14
Income After SG&A, R&D, and Dept/Amort Expenses 0.00 55.29 82.99 82.91 65.91
Non-Operating Income NA 2.05 1.14 0.92 1.32
Interest Expense NA 0.00 0.00 0.00 0.00
Pretax Income NA 57.34 84.14 83.82 67.23
Income Taxes NA 20.57 33.78 28.36 23.17
Minority Interest NA 0.00 0.00 0.00 0.00
Investment Gains/Losses NA 0.00 0.00 0.00 0.00
Other Income/Charges NA 0.00 0.00 0.00 0.00
Income From Cont. Operations NA 36.77 50.36 55.47 44.08
Extras & Discontinued Operations NA 0.00 0.00 0.00 0.00
Net Income NA 36.77 50.36 55.47 44.08
Earnings Per Share Data 6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Average Shares NA 76.37 76.83 81.80 82.64
Diluted EPS Before Non-Recurring Items NA 0.60 0.66 0.68 0.53
Diluted Net EPS NA 0.48 0.66 0.68 0.53
 

MYGN Chart by YCharts